Financial Results
for the FY Ended March 2017

Keigo Matsubara,
Representative Director, Senior Executive Managing Officer,
Chief Financial Officer

Kimiro Shiotani,
Managing Officer, Global Controller

• Summary of Operating Results for the FY Ended March 2017

• Operating Results for the FY Ended March 2017 (1)

• Operating Results for the FY Ended March 2017 (2)

• Cash Flow from Asset Recycling and Investments & Loans for the FY Ended March 2017

• Cumulative Cash Flow Allocation Results for the Three Years of the Previous Medium-Term Management Plan

• Cash Flow & Balance Sheets

• Return to Shareholders for the FY Ended March 2017

• EBITDA for the FY Ended March 2017 (YoY Comparison)

• Profit by Operating Segment for the Year ended March 2017 (YoY comparison)

• Breakdown in YoY Change in Profit for the year ended March 2017

• Q1 of FY ended March 2017: Activities based on Key Initiatives (announced May 2016)

• Q2 of FY ended March 2017: Activities based on Key Initiatives (announced May 2016)

• Q3 of FY ended March 2017: Activities based on Key Initiatives (announced May 2016)

• Q4 of the FY ended March 2017: Activities based on Key Initiatives (announced May 2016)

• Oil Price and Iron Ore Spot Prices

• Equity Share of Delivery (results)

• YoY EBITDA and Core Operating Cash Flow Comparison for the FY ended March 2017

• Quarterly Profit (Loss) Trends

• Major Projects in Mineral & Metal Resources Business

• Upstream Midstream Assets in Energy Business

• Upstream Midstream Assets (Natural Gas/LNG/Oil)

• Portfolio of Investments in Steel Products Business

• Portfolio of IPP (Independent Power Producer) Business

• Portfolio of Automotive-Related Business

• Other Major Machinery & Infrastructure Business

• Major Investments in Chemical Business

• Major Investments in Food and Retail Management Business

• Major Investments in Healthcare, Service, and Consumer Business

• Major Investments in ICT Business

• Major Investments in Corporate Development Business

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6

• Q&A 7